Incidence and Predictors of Eosinophilic Myocardial Hypersensitivity in Patients Receiving Home Dobutamine.

Dagan M, Lankaputhra M, Yeung T, Tee SL, Bader I, Easton K, Linton A, McLean C, Taylor A, Bergin P, Kaye DM, Leet A, Hare JL, Patel HC. Incidence and Predictors of Eosinophilic Myocardial Hypersensitivity in Patients Receiving Home Dobutamine. J Cardiovasc Pharmacol. 2022 10 01; 80(4):623-628.

View in: PubMed

subject areas

Adult
Cardiotonic Agents
Dobutamine
Female
Heart Failure
Humans
Incidence
Male
Middle Aged
Milrinone
Myocardium

authors with profiles

Andrew Taylor, Ph.D.

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support